Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1

Andrew L. Mammen, James L. Gulley, Αναστασία Ζεκερίδου et al.|Annals of the Rheumatic Diseases|2018

Cited by 134